Latest News

Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses

What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the condition. Now, researchers have developed a new class of imaging agents that enables them to visualize tau protein aggregates, a pathological hallmark of Alzheimer's disease and related neurodegenerative disorders, directly in the brains of living patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • How to stop a stroke in its tracks

  • Significant increase in major depression reported during recent recession

  • Discovery may open door for treating fragile X carriers

  • Fat tissue controls brain's response to food scarcity, helping regulate optimal amount of body fat for brain function

  • Risk perception: Social exchange can amplify subjective fears

  • Psychology of the appeal of being anti-GMO

  • New light shed on brain's source of power

  • We think better on our feet, literally

  • Inclusive classrooms don't necessarily increase friendships for children with disabilities

  • New insight into how brain makes memories

  •